When ubiquitin meets NF-κB: a trove for anti-cancer drug development
about
Aberrant nuclear factor-kappa B activity in acute myeloid leukemia: from molecular pathogenesis to therapeutic targetTRAF Family Member-associated NF-κB Activator (TANK) Inhibits Genotoxic Nuclear Factor κB Activation by Facilitating Deubiquitinase USP10-dependent Deubiquitination of TRAF6 LigaseProtein ubiquitination in lymphoid malignancies.The novel β2-selective proteasome inhibitor LU-102 decreases phosphorylation of I kappa B and induces highly synergistic cytotoxicity in combination with ibrutinib in multiple myeloma cells.Jak1-STAT3 Signals Are Essential Effectors of the USP6/TRE17 Oncogene in Tumorigenesis.Genetic variations in the PSMA3, PSMA6 and PSMC6 genes are associated with type 1 diabetes in Latvians and with expression level of number of UPS-related and T1DM-susceptible genes in HapMap individuals.Bortezomib treatment induces a higher mortality rate in lupus model mice with a higher disease activity.Beta-catenin cleavage enhances transcriptional activation.Lycopene acts through inhibition of IκB kinase to suppress NF-κB signaling in human prostate and breast cancer cells.Promising Antineoplastic Actions of Melatonin
P2860
Q26995561-A830086D-D64B-4C47-A11B-B33BB565869EQ28118631-C69AE392-C01F-495D-AF3C-35367F6178D6Q34722684-964FB65B-A595-46F9-91C7-FD76E24A1060Q35889653-CFD2E6E5-C029-4753-A02B-0DFC33FCA36DQ38756741-EFE12FE5-3F79-472F-AF58-A50EFC8A71C9Q40217776-269752EF-2CC5-465B-8F9E-B351881EA0C7Q41363502-38817CD0-DE3B-4C0B-8091-A037275B2E24Q48251360-73203E85-DFCD-462A-90F5-B1707A6B5D63Q53205806-179F99F8-36BD-4761-B71D-7862BAC41E26Q58554204-CAFD83A7-19ED-48BA-9CDF-859536D5937B
P2860
When ubiquitin meets NF-κB: a trove for anti-cancer drug development
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
When ubiquitin meets NF-κB: a trove for anti-cancer drug development
@ast
When ubiquitin meets NF-κB: a trove for anti-cancer drug development
@en
When ubiquitin meets NF-κB: a trove for anti-cancer drug development
@nl
type
label
When ubiquitin meets NF-κB: a trove for anti-cancer drug development
@ast
When ubiquitin meets NF-κB: a trove for anti-cancer drug development
@en
When ubiquitin meets NF-κB: a trove for anti-cancer drug development
@nl
prefLabel
When ubiquitin meets NF-κB: a trove for anti-cancer drug development
@ast
When ubiquitin meets NF-κB: a trove for anti-cancer drug development
@en
When ubiquitin meets NF-κB: a trove for anti-cancer drug development
@nl
P2860
P1476
When ubiquitin meets NF-κB: a trove for anti-cancer drug development
@en
P2860
P304
P356
10.2174/1381612811319180010
P407
P577
2013-01-01T00:00:00Z